SORRISO PHARMACEUTICALS

Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn’s disease and ulcerative colitis. The Sorriso platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the intestinal system. The company was founded in 2020 and is based in San Diego, California.

#SimilarOrganizations #People #Financial #Website #More

SORRISO PHARMACEUTICALS

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2020-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.sorrisopharma.com

Status:
Active

Email Addresses:
[email protected]

Total Funding:
31 M USD


Similar Organizations

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

Current Employees Featured

ciara-kennedy_image

Ciara Kennedy
Ciara Kennedy Founder, President and CEO @ Sorriso Pharmaceuticals
Founder, President and CEO

Founder


ciara-kennedy_image

Ciara Kennedy

not_available_image

Susan Dubé

Investors List

arix-bioscience_image

Arix Bioscience

Arix Bioscience investment in Series A - Sorriso Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series A - Sorriso Pharmaceuticals

Official Site Inspections

http://www.sorrisopharma.com

  • Host name: cloudproxy10026.sucuri.net
  • IP address: 192.124.249.26
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Sorriso Pharmaceuticals"

Sorriso Pharmaceuticals - Crunchbase Company Profile & Funding

Contact Email [email protected] Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory …See details»

Sorriso Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...

Www.sorrisopharma.com. Holding Company | 2020 | California, United States | 10-50 | www.sorrisopharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»

Sorriso Pharmaceuticals: Contact Details and Business Profile

Sorrisopharma.com; Pamela Wedel SVP, Clinical Development and Operations at Sorriso Pharmaceuticals San Diego, CA, US View. 2 amplyx.com; sorrisopharma.com; 3 …See details»

Sorriso Pharmaceuticals Overview | SignalHire Company Profile

Organization Website: sorrisopharma.com : Phone Number (385) 342-4989: Sorriso Pharmaceuticals industries Biotech: Headquarters Location: San Diego, CA, US San Diego, …See details»

Sorriso Pharmaceuticals - PitchBook

Sorriso Pharmaceuticals General Information Description. Developer of disease-modifying antibodies designed for the treatment of inflammatory diseases, including Crohn's disease and …See details»

Investors - Sorriso Pharmaceuticals

Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada.See details»

Sorriso Pharmaceuticals - Craft

Sorriso Pharmaceuticals $31 m in total funding,. See insights on Sorriso Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»

Sorriso Pharmaceuticals - VentureRadar

Similar Companies: VHsquared United Kingdom Closed Down (Assumed) VHsquared is dedicated to developing a portfolio of products targeted at benefitting gastro intestinal (GI) …See details»

Sorriso Pharmaceuticals | LinkedIn

Sorriso Pharmaceuticals | 474 followers on LinkedIn. Harnessing the power of oral biologic therapies for patients with chronic illness | Sorriso’s mission is to harness the power of oral ...See details»

About - Sorriso Pharmaceuticals

Corporate Headquarters 9295 S. 1300 E. #3, Sandy, UT 84094. San Diego, CA. Lab Headquarters Magnify at CNSI, UCLA, Los Angeles, CASee details»

Sorriso Pharmaceuticals Inc. - life-sciences-europe.com

Jun 10, 2020 Upcoming Events. Stifel Healthcare Conference 2025 New York; Formnext 2025 Frankfurt am Main; Deutsches Eigenkapitalforum 2025 Frankfurt (German Equity Forum 2025)See details»

Sorriso Pharmaceuticals - Incubating Companies

Market: Sorriso’s products are designed to block multiple molecular targets that drive inflammation, as validated by rigorous research. The company’s biologic therapies are …See details»

Overview, News & Similar companies - ZoomInfo.com

Dec 27, 2021 View Sorriso Pharmaceuticals (www.sorrisopharma.com) location in Campania, Italy , revenue, industry and description. Find related and similar companies as well as …See details»

Sorriso Pharmaceuticals - Work in biotech

Sorriso Pharmaceuticals is developing novel orally delivered cytokine antibodies for the treatment of inflammatory diseases. Their proprietary platform, Vorabodies, leverages single-domain …See details»

Pipeline - Sorriso Pharmaceuticals

Sæ§1 éI«õCf$+µ=¼Dä¤Õ : cÜÐ ¿þüû/ Á1 ÿ0-Ûq=^Ÿßÿûæò¿'?_ qˆ­Ž$kóš1tJ¡ÛÂLßB8s [ j ÛÇRHh°Îö¥ì ŠÐ ¥$çÆ|±kWÜß«šÕvS½£ƒ ...See details»

Sorriso Pharmaceuticals - Pappas Capital

Sorriso is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including Crohn’s disease and ulcerative colitis.See details»

Sorriso Pharmaceuticals - Products, Competitors, Financials, …

For more information about Sorriso and its ongoing clinical trials, please visit www.sorrisopharma.com . About SOR102 SOR102 simultaneously inhibits TNF⍺ and IL …See details»

Platform - Sorriso Pharmaceuticals

Vorabodies are single domain antibodies that are specifically engineered to directly access and maintain activity within inflamed tissue. Our platform combines multiple unique attributes to …See details»

www.sorrisopharma.us

Www.sorrisopharma.usSee details»

linkstock.net © 2022. All rights reserved